Double-stranded viral RNA persists in vitro and in vivo during prolonged infection of porcine reproductive and respiratory syndrome virus

Virology
Rui GuoYing Fang

Abstract

In order to study the mechanism of PRRSV persistence, an in vitro model of persistence was developed by serially passaging PRRSV-infected MARC-145 cells 109 times. Viral persistence was detected to be associated with increased double-stranded (dsRNA) in the infected cells. In PRRSV infected pigs, reduced ratio of plus to minus strands of viral RNA was observed in lymphoid tissues from PRRSV persistent pigs at 52 days post infection. Viral dsRNA was mostly detected in the germinal center during persistent infection compared to the localization of dsRNA in the inter-follicular zones during acute infection. RNA array analysis of antiviral cytokines in persistently infected lymph nodes showed that the presence of dsRNA did not stimulate antiviral immunity. These results suggest that PRRSV dsRNA functions as a mediator for viral persistence. The localization of PRRSV dsRNA in the germinal center of lymphoid tissues reveals a novel mechanism for PRRSV persistence.

References

Dec 1, 1991·The Journal of Infectious Diseases·C H FoxA S Fauci
Apr 1, 1997·Veterinary Microbiology·R W WillsE A Nelson
Aug 12, 1999·Clinical and Experimental Immunology·G VanhamJ L Ceuppens
Mar 20, 2002·Veterinary Microbiology·Dennis C HorterJeffrey J Zimmerman
Jul 20, 2004·Journal of Medical Virology·Paul K S ChanHo-Keung Ng
Oct 28, 2004·Veterinary Immunology and Immunopathology·O J Lopez, F A Osorio
Jul 1, 2006·Biochemical and Biophysical Research Communications·Tetsuya MizutaniShigeru Morikawa
May 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elizabeth ConnickPamela J Skinner
Aug 19, 2007·Cytokine & Growth Factor Reviews·Michael P Gantier, Bryan R G Williams
Feb 19, 2008·Nature Biotechnology·Gary K GeissKrassen Dimitrov
Jun 27, 2008·Journal of Virology·Jianqiang ZhangUdeni B R Balasuriya
Sep 6, 2008·Transboundary and Emerging Diseases·R M MolinaJ J Zimmerman
Nov 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·James E StrongHeinz Feldmann
Dec 4, 2009·Journal of Virology·Melissa Kane, Tatyana Golovkina
Jul 9, 2011·Nature Immunology·Stephen L Nutt, David M Tarlinton
Oct 9, 2012·Proceedings of the National Academy of Sciences of the United States of America·Ying FangAndrew E Firth
Oct 11, 2012·Frontiers in Immunology·Mohey Eldin M El Shikh, Costantino Pitzalis
Aug 14, 2013·The Journal of General Virology·Eric J SnijderYing Fang
Sep 21, 2013·Nature Immunology·Luke C DaviesPhilip R Taylor
May 16, 2014·Proceedings of the National Academy of Sciences of the United States of America·Yanhua LiYing Fang
Dec 10, 2015·Annual Review of Animal Biosciences·Joan K LunneyGourapura J Renukaradhya
Feb 14, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stephanie L KohlerElizabeth Connick
Jul 28, 2016·Frontiers in Microbiology·Obdulio García-NicolásArtur Summerfield
Sep 20, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Arielle KlepperAndrea D Branch
Nov 29, 2016·Frontiers in Immunology·Stéphanie Graff-DuboisArnaud Moris
Mar 21, 2017·Current Opinion in Virology·Richard E Randall, Diane E Griffin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.